Search - tctmd.com

Displaying 541 - 560 of 764

Sort: Relevancy | Date

News Daily News

Las Noticias Más Leídas del “Top 10” de TCTMD en 2012

Jason Kahn

January 02, 2013

News Daily News

ROTAXUS Published: Rotational Atherectomy Does Not Increase DES Efficacy

Yael L. Maxwell

December 27, 2012

News Daily News

EES Outperform First-Generation DES in Treatment of CTOs

L.A. McKeown

December 27, 2012

News Daily News

Una Dosis Alta de Aspirina tras una PCI Primaria aumenta las Hemorragias No observandose Beneficio Isquémico alguno

L.A. McKeown

December 19, 2012

News Daily News

High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit

L.A. McKeown

December 19, 2012

News Daily News

Un Meta Análisis estudia el Bypass frente a la Terapia Endovascular en las Lesiones Femoropoplíteas

L.A. McKeown

December 12, 2012

News Daily News

Meta-analysis Looks at Bypass vs. Endovascular Therapy for Femoropopliteal Lesions

L.A. McKeown

December 12, 2012

News Daily News

Su Publica el PACIFIER: Los Balones liberadores de Fármacos Ayudan a tratar las Lesiones Femoropoplíteas

Caitlin E. Cox

December 09, 2012

News Daily News

PACIFIER Published: Drug-Eluting Balloon Helps Treat Femoropopliteal Lesions

Caitlin E. Cox

December 09, 2012

Presentation

Paclitaxel-Coated Balloons Reduce Restenosis After Femoropopliteal Angioplasty

Presenter: Michael Werk

December 06, 2012

News Daily News

Zilver Stent Seen as Welcome Addition to PAD Armamentarium

L.A. McKeown

November 25, 2012

News Daily News

Stent Zilver parece ser una adición bienvenida al arsenal de PAD

L.A. McKeown

November 25, 2012

News Daily News

BELLO: Drug-Coated Balloons Take on De Novo Lesions vs. DES

Caitlin E. Cox

November 15, 2012

News Daily News

BELLO: Balones recubiertos de Fármacos contra Lesiones De Novo frente a SLF

Caitlin E. Cox

November 15, 2012

Presentation

BELLO: Paclitaxel Drug-Eluting Balloons vs. Paclitaxel-Eluting Stents in Small Coronary Vessels

Presenter: A. Latib

November 13, 2012

Presentation TCT 2012

ISAR-DESIRE 3: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons vs. Paclitaxel-Eluting Stents vs. Balloon Angioplasty for Restenosis of Limus-Eluting Coronary Stents

Presenter: Robert Byrne

October 26, 2012

News Conference News TCT 2012

Paclitaxel-Eluting Balloon Results in High Patency Rate at 1 Year in Below-the-Knee Lesions

October 25, 2012

Presentation TCT 2012

Paclitaxel Delivery and Tissue Effects: Similarities and Critical Differences with DES

Presenter: Renu Virmani

October 25, 2012

Presentation TCT 2012

Impact of Paclitaxel Formulation on Drug Transfer, Tissue Pharmacokinetics, and Biological Activity

Presenter: Juan Granada

October 25, 2012

Presentation TCT 2012

DEBATE-BTK: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty in Diabetic Patients with Critical Limb Ischemia Undergoing Angioplasty of Below-the-Knee...

Presenter: Francesco Liistro

October 25, 2012

Advertisement

Las Noticias Más Leídas del “Top 10” de TCTMD en 2012

ROTAXUS Published: Rotational Atherectomy Does Not Increase DES Efficacy

EES Outperform First-Generation DES in Treatment of CTOs

Una Dosis Alta de Aspirina tras una PCI Primaria aumenta las Hemorragias No observandose Beneficio Isquémico alguno

High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit

Un Meta Análisis estudia el Bypass frente a la Terapia Endovascular en las Lesiones Femoropoplíteas

Meta-analysis Looks at Bypass vs. Endovascular Therapy for Femoropopliteal Lesions

Su Publica el PACIFIER: Los Balones liberadores de Fármacos Ayudan a tratar las Lesiones Femoropoplíteas

PACIFIER Published: Drug-Eluting Balloon Helps Treat Femoropopliteal Lesions

Paclitaxel-Coated Balloons Reduce Restenosis After Femoropopliteal Angioplasty

Zilver Stent Seen as Welcome Addition to PAD Armamentarium

Stent Zilver parece ser una adición bienvenida al arsenal de PAD

BELLO: Drug-Coated Balloons Take on De Novo Lesions vs. DES

BELLO: Balones recubiertos de Fármacos contra Lesiones De Novo frente a SLF

BELLO: Paclitaxel Drug-Eluting Balloons vs. Paclitaxel-Eluting Stents in Small Coronary Vessels

ISAR-DESIRE 3: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons vs. Paclitaxel-Eluting Stents vs. Balloon Angioplasty for Restenosis of Limus-Eluting Coronary Stents

Paclitaxel-Eluting Balloon Results in High Patency Rate at 1 Year in Below-the-Knee Lesions

Paclitaxel Delivery and Tissue Effects: Similarities and Critical Differences with DES

Impact of Paclitaxel Formulation on Drug Transfer, Tissue Pharmacokinetics, and Biological Activity

DEBATE-BTK: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty in Diabetic Patients with Critical Limb Ischemia Undergoing Angioplasty of Below-the-Knee...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content